Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

Bonadonna G, 1975, Proc Am Assoc Cancer Res Am Soc Clin Oncol, 16, 254

10.1056/NEJM197602192940801

10.1056/NEJM197501162920301

1992, Lancet, 399, 1

10.1056/NEJM198101013040103

10.2307/2281868

10.2307/2344317

Cox DR, 1972, J R Stat Soc [B], 34, 187

Miller RG. Survival analysis. New York: John Wiley, 1981.

Valagussa P, 1989, Recent Results Cancer Res, 115, 69, 10.1007/978-3-642-83337-3_10

Valagussa P, 1994, Ann Oncol, 5, 803, 10.1093/oxfordjournals.annonc.a059008

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

10.1056/NEJM199405053301801

Moliterni A, 1991, J Clin Oncol, 9, 1124, 10.1200/JCO.1991.9.7.1124

10.1001/jama.273.7.542

Fisher B, 1990, J Clin Oncol, 8, 1483, 10.1200/JCO.1990.8.9.1483

Goldhirsch A, 1990, Ann Oncol, 1, 183, 10.1093/oxfordjournals.annonc.a057718

10.1016/S0140-6736(94)91221-1

10.1002/1097-0142(19900501)65:9+<2132::AID-CNCR2820651410>3.0.CO;2-4